The deal entails an equity infusion to accelerate the expansion of the Medima network and a direct share purchase facilitating a partial exit for Morphosis.
“Over the past two years, we have expanded our business, democratizing access to high quality radiology services for the Romanian people. We are excited to continue this growth story with our new partners, Integral, to take the Medima business to the next level,” says Vlad Ardeleanu, co-owner and CEO of Medima Health.
Medima Health is a network specializing in complex imaging through MRI, CT and PET-CT scanning, oncology diagnostics and teleradiology. The Medima team is led by radiologist Gheorghe Iana, who also serves as the network’s medical director.
The company operates nine clinics in Bucharest, Alba Iulia, Braila, Buzau, Calarasi and Sibiu. Medima will also open its first integrated oncology and radiology center in Targu Mures soon, providing patients with access to a cyclotron, which offers some of the most advanced diagnostic methods in oncology.
Morphosis Capital invested in Medima in September 2020, committing to create a major player in imaging and radiology services with a regional presence throughout Romania, with a mission to democratize access to quality imaging equipment and infrastructure.
(English version by Loredana Fratila-Cristescu)